MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential-Reference-Cited by-同舟云学术

MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential

Published:2022-01-11 Issue:4 Volume:26 Page:977-989
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Sha Huanhuan¹,Gan Yujie¹,Xu Feng²,Zhu Yue¹,Zou Renrui¹,Peng Weiwei¹,Wu Zhiya¹,Ma Rong¹,Wu Jianzhong¹,Feng Jifeng¹^ORCID

Affiliation:

1. Department of Chemotherapy Jiangsu Cancer Hospital Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiangsu China

2. School of Basic Medical Sciences Xinxiang Medical University Xinxiang Henan China

Funder

National Natural Science Foundation of China

Government of Jiangsu Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17161

Reference87 articles.

1. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

2. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

3. MicroRNAs in Cancer

4. MiRNAs from DLK1-DIO3 Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases Signaling

5. MicroRNA‐381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial‐to‐mesenchymal transition;Xuan YW;Eur Rev Med Pharmacol Sci,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4;Biochemistry and Biophysics Reports;2023-12

2. miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review;International Journal of Molecular Sciences;2023-05-09

3. Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment;Small;2023-03-28

4. Curcumin: An epigenetic regulator and its application in cancer;Biomedicine & Pharmacotherapy;2022-12